Loading...
Xvivo Perfusion AB (publ)
XVIPY•PNK
Healthcare
Medical - Specialties
$6.54
$0.00(0.00%)
U.S. Market opens in 8h 3mXvivo Perfusion AB (publ) (XVIPY) AI-Powered Stock Analysis
See how Xvivo Perfusion AB (publ) scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerXvivo Perfusion AB (publ) (XVIPY) Stock Overall Grade
Xvivo Perfusion AB (publ)’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Xvivo Perfusion AB (publ)'s overall stock rating.
Forecast
C+Score
59/100Financial Growth
A+Score
100/100Fundamental Growth
C+Score
59/100Key Ratios
BScore
64/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
C+Score
50/100Xvivo Perfusion AB (publ) (XVIPY) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 59/100 (C+), reflecting weak confidence in its potential. Financial Growth (100/100, A+) and Fundamental Growth (59/100, C+) highlight its stability, while Key Ratios (64/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Xvivo Perfusion AB (publ) stock grade, including financials, comparisons, and forecasts.